Applied Therapeutics, Inc.
APLT
$0.4101
-$0.0309-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -94.08% | -119.93% | -178.41% | -45.15% | -1.34% |
| Total Depreciation and Amortization | -23.81% | -19.56% | -19.82% | -20.09% | 6.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 135.75% | 386.58% | 1,021.48% | 412.46% | 147.01% |
| Change in Net Operating Assets | 59.72% | -18.03% | -7.38% | 83.71% | 75.15% |
| Cash from Operations | -51.39% | -24.71% | -10.58% | 29.35% | 39.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -100.00% | 5.33% | -78.15% |
| Cash from Investing | -100.00% | -100.00% | -100.00% | 5.33% | -78.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 66.64% | 55.57% | 50.19% | 43.23% | 34.00% |
| Issuance of Common Stock | 224.23% | 483.11% | 583.40% | 168.30% | 61.07% |
| Repurchase of Common Stock | -- | -4,238.46% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -50.21% | -50.21% | -50.15% |
| Cash from Financing | 224.37% | 500.26% | 584.38% | 169.18% | 60.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,195.19% | 530.49% | 907.79% | 189.28% | 90.17% |
